![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
November 21, 2025
A recap of the Fall 2025 Group Meeting, trial results from ESMO, and a look ahead to the ASH Annual Meeting and Exposition and the San Antonio Breast Cancer Symposium
November 21, 2025
Several themes emerged as key areas of focus for ECOG-ACRIN during the Fall 2025 Group Meeting
November 21, 2025
In an annual evaluation, 37 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
November 21, 2025
Compliance guidance for an updated policy that aims to accelerate free public access to research funded by the National Institutes of Health
November 21, 2025
This clinical trial is exploring whether PARP inhibitors will improve outcomes for patients with early-stage pancreas cancer that has BRCA or PALB2 mutations
November 21, 2025
The latest clinical trial findings in follicular lymphoma, prostate cancer, precision medicine, and symptom science
November 21, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more